Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |